TREATMENT SET TS343825 injection, solution
TREATMENT SET TS343826 injection, solution
TREATMENT SET TS344001 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts343825 injection, solution treatment set ts343826 injection, solution treatment set ts344001 injection, soluti

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - alternaria alternata 0.01 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

MOLD ANTIGENS (alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, torula cerevisiae, mucor racem United States - English - NLM (National Library of Medicine)

mold antigens (alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, torula cerevisiae, mucor racem

energique, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), candida parapsilosis (unii: 0kz676d44n) (candida parapsilosis - unii:0kz676d44n), saccharomyces cerevisiae (unii: 978d8u419h) (saccharomyces cerevisiae - unii:978d8u419h), mucor racemosus (unii: 17rh99lq7g) (mucor racemosus - unii:17rh99lq7g), arsenic - may temporarily relieve symptoms associated with mold allergies, such as runny nose.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve symptoms associated with mold allergies, such as runny nose.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

SORREL/DOCK MIX- rumex acetosella pollen and rumex crispus pollen injection, solution
MIXED MOLDS- alternaria alternata, asperg United States - English - NLM (National Library of Medicine)

sorrel/dock mix- rumex acetosella pollen and rumex crispus pollen injection, solution mixed molds- alternaria alternata, asperg

alk-abello, inc. - rumex acetosella pollen (unii: n52miq81zw) (rumex acetosella pollen - unii:n52miq81zw), rumex crispus pollen (unii: v825xjg64g) (rumex crispus pollen - unii:v825xjg64g) - alternaria alternata 0.1 g in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

OHM ALLERGY MOLD MIX- alternaria alt, aspergillus fum, aspergillus nig, boletus sat, botrytis cin, candida alb, cladosporium met United States - English - NLM (National Library of Medicine)

ohm allergy mold mix- alternaria alt, aspergillus fum, aspergillus nig, boletus sat, botrytis cin, candida alb, cladosporium met

ohm pharma inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), boletus satanas fruiting body (unii: 68og1407sm) (boletus satanas fruiting body - unii:68og1407sm), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21h - uses: temporarily relieves sneezing, runny nose, itchy eyes associated with exposure to molds and fungi.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

CANDIDA SPP- alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, mucor racemosus, pullularia pull United States - English - NLM (National Library of Medicine)

candida spp- alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, mucor racemosus, pullularia pull

deseret biologicals, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), candida parapsilosis (unii: 0kz676d44n) (candida parapsilosis - unii:0kz676d44n), mucor racemosus (unii: 17rh99lq7g) (mucor racemosus - unii:17rh99lq7g), aureobasidium pullulans var. pullutans (unii: d1a2ng69ck) (aureobasidium pullulans var. pullutans - for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

A-21- alternaria alternata, aspergillus niger var. niger, cochliobolus spicifer, gibberella fujikuroi, cochliobolus sativus, cla United States - English - NLM (National Library of Medicine)

a-21- alternaria alternata, aspergillus niger var. niger, cochliobolus spicifer, gibberella fujikuroi, cochliobolus sativus, cla

dna labs, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), cochliobolus spicifer (unii: 91m9rwp3td) (cochliobolus spicifer - unii:91m9rwp3td), gibberella fujikuroi (unii: 815v716or2) (gibberella fujikuroi - unii:815v716or2), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium bruhnei (unii: r1786y8h66) (cladosporium bruhnei - unii:r1786y8h6 - allergies.

ALLERGY ATLANTIC MOLD MIX- alternaria alternata, aspergillus fumigatus, botrytis cinerea, rhizopus stolonifer, ustilago maydis l United States - English - NLM (National Library of Medicine)

allergy atlantic mold mix- alternaria alternata, aspergillus fumigatus, botrytis cinerea, rhizopus stolonifer, ustilago maydis l

natural creations, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), rhizopus stolonifer (unii: fee198dk4q) (rhizopus stolonifer - unii:fee198dk4q), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg) - uses :  temporarily relieves symptoms related to mold allergies.** uses :  temporarily  relieves symptoms related to mold allergies.**

MOLD MIX A- alternaria alternata, aspergillus fumigatus, cladosporium cladosporioides and penicillium chrysogenum var. chrysogen United States - English - NLM (National Library of Medicine)

mold mix a- alternaria alternata, aspergillus fumigatus, cladosporium cladosporioides and penicillium chrysogenum var. chrysogen

alk-abello, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

MOLD MIX A- alternaria alternata, aspergillus fumigatus, cladosporium cladosporioides and penicillium chrysogenum var. chrysogen United States - English - NLM (National Library of Medicine)

mold mix a- alternaria alternata, aspergillus fumigatus, cladosporium cladosporioides and penicillium chrysogenum var. chrysogen

alk-abello, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse